Study Title: Breakthrough SARS-CoV-2 infections among patients with cancer following two and three doses of COVID-19 mRNA vaccines Publication (online): The Lancet Regional Health – Americas, February 13,...
Harmonized approach and vast database of trial participants could bolster future research well beyond SARS-CoV-2 Newswise — SEATTLE – The federally funded COVID-19 Prevention Network (CoVPN), headquartered...
A new study finds that antibodies produced in the nose decline nine months after COVID-19 infection, while antibodies found in the blood last at least a...
As the lead pastor of Macedonia Baptist Church, Rev. Dr. Shane B. Scott is accustomed to hearing from parishioners. But on one occasion, the words spoken...
The transition to telehealth-based care at the onset of the COVID-19 pandemic was followed by an increase in initiation of and engagement with specialty alcohol treatment,...
Newswise — The United States Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA), which was immediately endorsed by the U.S. Centers for Disease...
The FDA amended the emergency use authorizations of the Moderna COVID-19 Vaccine, Bivalent and the Pfizer-BioNTech COVID-19 Vaccine, Bivalent to authorize their use as a single...
The COVID-19 pandemic continues to change the way people spend time in their homes. From work to working out, more out-of-the-house activities have moved to the...
The paper test measures the level of neutralizing antibodies in a blood sample and could help people decide what protections they should take against infection. Newswise...
